Lapatinib ditosylate monohydrate - CAS 388082-78-8

Lapatinib ditosylate (Lapatinib tosilate) monohydrate is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib ditosylate monohydrate therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.

Ferroptosis, Autophagy, EGFR

JAK/STAT signaling, Tyrosine Kinase/Adaptors, Autophagy, Apoptosis, Angiogenesis

387996

>99.99%

C29H26ClFN4O4S·2 (C7H8O3S) ·H2O

943.47

n1cnc(c2cc(ccc12)c1oc(cc1)CNCCS(=O)(=O)C)Nc1cc(c(cc1)OCc1cc(ccc1)F)Cl.c1(ccc(cc1)C)S(=O)(=O)O.O.c1(ccc(cc1)C)S(=O)(=O)O

-20°C

Ice Packs

Small Compound